BCRX
BioCryst Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
BioCryst Pharmaceuticals (BCRX) Stock: Buy, Sell, or Hold?
$7.65
+0.12 (+1.59%)
▲
5d:
-7.16%
30d:
-5.2%
90d:
-22.02%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect BCRX Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (57%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$7.73 – $8.36
Position: OVERSOLD
Forward P/E & Valuation
9.0x
CHEAP
vs 13.8x historical avg
Wall Street Target
$20.45
+167.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.38 / $8.86
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BCRX shows conflicting indicators. Wait for confirmation before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 5, 2026 at $7.64 · last confirmed Nov 9, 2026
Strength: 8.0/10
Get Alerted When BCRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.64
Based on 1.4% avg growth
INTRINSIC VALUE TODAY
$7.85
2.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BCRX is currently trading at $7.65, which is considered oversold relative to its 30-day fair value range of $7.73 to $8.36. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.9) compared to its historical average (13.8). Remarkably, the market is currently pricing in an annual earnings decline of 13.5% over the next few years. This pessimistic expectation contrasts with the company's recent 133.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BCRX is in a strong downtrend. Immediate support is located at $7.38, while resistance sits at $8.86.
Market Sentiment: BCRX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.45 (+167.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BCRX is in a strong downtrend. Immediate support is located at $7.38, while resistance sits at $8.86.
Market Sentiment: BCRX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.45 (+167.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.73 -
$8.36
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$7.73 -
$8.36
Current vs Trading Range
OVERSOLD
Support Level
$7.38
Resistance Level
$8.86
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding BCRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 167.4% below Wall St target ($20.45)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
8.95
Wall Street Target
$20.45
(+167.4%)
Revenue Growth (YoY)
13.1%
Earnings Growth (YoY)
133.3%
Profit Margin
-37.4%
Valuation Discount vs History
-13.5% cheaper
PE vs Historical
9.0 vs 13.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.5%
(market-implied from PE analysis)
1-Year Target
$6.88
(-10%)
2-Year Target
$6.20
(-19%)
3-Year Target
$5.58
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→14)
$8.60
(+12%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -1.2%)
$16.40
(+114%)
Base:
(SPY PE: 8.9, Growth: -1.2%)
$7.39
(-3%)
Bear:
(PE: 7.6, Growth: -1.2%)
$6.28
(-18%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.9 to 13.8
Stabilization Target:
$11.80
(+54.2%)
PE Expansion Potential:
+54.2%
Share BCRX Analysis
Share this live BCRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCRX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expressed profitability after averaging down on $BCRX shares from $8.08 to $7.62.
Key Retail Themes:
Price action
Profit-taking
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:11 AM ET
Data refreshes hourly during market hours. Next update: 3:11 AM
Data refreshes hourly during market hours. Next update: 3:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Advanced BCRX Option Strategies
Professional options setups generated by AI based on today's BCRX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCRX Research Pages
